search
Back to results

Intracochlear Potentials: Volta Study (CLTD5663)

Primary Purpose

Hearing Loss

Status
Completed
Phase
Not Applicable
Locations
Australia
Study Type
Interventional
Intervention
SA16 research software
CS19 (1.6.2)
Sponsored by
Cochlear
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Hearing Loss focused on measuring Voltage tomography

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Meet current cochlear implant indications at the implanting centre for a Cochlear Nucleus CI512, CI422, CI522 or CI532 cochlear implant
  2. Aged 18 years and older at the time of implantation.

Exclusion Criteria:

  1. Recipient of a Nucleus 24 ABI device
  2. Medical or psychological conditions that contraindicate undergoing general anaesthesia or surgery.
  3. Ossification, malformation or any other cochlear anomaly, such as common cavity, that might prevent complete insertion of the electrode array, as confirmed by medical examination.
  4. Unwillingness or inability of the candidate to comply with all investigational requirements.

Sites / Locations

  • The Hearing Cooperative Research Centre
  • Royal Victorian Eye and Ear Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Voltage tomography

Arm Description

Voltage tomography measurements will be made with the SA16 research software and CS19 (1.6.2) software during and/or immediately after electrode insertion during cochlear implantation and at scheduled post-operative clinical visits.

Outcomes

Primary Outcome Measures

Normative Voltage Tomography Data
Gather normative voltage tomography data for retrospective analysis. After insertion of the electrode array, TIM measurements will be taken from each subject using the cochlear implant system and Surgical Assistant Research Tool software. A Tip Foldover (TFO) in the software and x-rays will be used to identify any occurrence of a tip foldover.

Secondary Outcome Measures

Full Information

First Posted
June 3, 2016
Last Updated
October 12, 2022
Sponsor
Cochlear
Collaborators
The Hearing Cooperative Research Centre, Royal Victoria Eye and Ear Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02852330
Brief Title
Intracochlear Potentials: Volta Study
Acronym
CLTD5663
Official Title
Intracochlear Potentials: Intraoperative and Post-operative Measurement Clinical Investigation
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
July 10, 2017 (Actual)
Primary Completion Date
October 10, 2018 (Actual)
Study Completion Date
October 10, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Cochlear
Collaborators
The Hearing Cooperative Research Centre, Royal Victoria Eye and Ear Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Collection of normative voltage tomography data during and/or immediately after electrode insertion into the cochlea using Surgical Assistant (SA16) research software and postoperatively at activation, three and twelve months post-activation with CS19 research software in adults who are receiving a Cochlear Nucleus CI512, CI422, CI522 or CI532 cochlear implant.
Detailed Description
The clinical investigation will gather impedance and transimpedance (voltage tomography) data intraoperatively and post-operatively which can be used to characterize the electrical properties of the living cochlea. The Surgical Assistant Research Tool (SA16) research software is a software tool developed by Cochlear Limited. The use of the SA16 research software in the current clinical investigation is intended to support Cochlear's research into the development of implant telemetry based surgical tools. The SA16 research software is designed to perform a series of predefined measurements with minimal intervention both during and immediately following electrode insertion using telemetry from the implant via the Sound Processor to the computer. These measurements include real time continuous measurements, intended for use during the electrode insertion portion of the surgical procedure, and baseline measurements following the completion of electrode insertion. The SA16 research software will be used in the current clinical investigation in adults who meet current indications for cochlear implantation in Australia. The SA16 research software is not for use with patients who are receiving an implant that directly contacts neural tissue, such as auditory brainstem implants (ABI). CS19 (1.6.2) software will be used to collect voltage tomography measurements post-implantation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hearing Loss
Keywords
Voltage tomography

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Voltage tomography
Arm Type
Experimental
Arm Description
Voltage tomography measurements will be made with the SA16 research software and CS19 (1.6.2) software during and/or immediately after electrode insertion during cochlear implantation and at scheduled post-operative clinical visits.
Intervention Type
Device
Intervention Name(s)
SA16 research software
Intervention Description
Software for measurement of voltage tomography intraoperatively.
Intervention Type
Device
Intervention Name(s)
CS19 (1.6.2)
Intervention Description
Software for measurement of voltage tomography post-operatively.
Primary Outcome Measure Information:
Title
Normative Voltage Tomography Data
Description
Gather normative voltage tomography data for retrospective analysis. After insertion of the electrode array, TIM measurements will be taken from each subject using the cochlear implant system and Surgical Assistant Research Tool software. A Tip Foldover (TFO) in the software and x-rays will be used to identify any occurrence of a tip foldover.
Time Frame
intraoperatively during and/or immediately after electrode insertion into the cochlea, with a measurement time of approximately 10 minutes.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Meet current cochlear implant indications at the implanting centre for a Cochlear Nucleus CI512, CI422, CI522 or CI532 cochlear implant Aged 18 years and older at the time of implantation. Exclusion Criteria: Recipient of a Nucleus 24 ABI device Medical or psychological conditions that contraindicate undergoing general anaesthesia or surgery. Ossification, malformation or any other cochlear anomaly, such as common cavity, that might prevent complete insertion of the electrode array, as confirmed by medical examination. Unwillingness or inability of the candidate to comply with all investigational requirements.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert Cowan
Organizational Affiliation
The HEARing CRC
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Robert Briggs
Organizational Affiliation
The Royal Victorian Eye and Ear Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Hearing Cooperative Research Centre
City
Carlton
State/Province
Victoria
ZIP/Postal Code
3053
Country
Australia
Facility Name
Royal Victorian Eye and Ear Hospital
City
East Melbourne
State/Province
Victoria
ZIP/Postal Code
30002
Country
Australia

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Intracochlear Potentials: Volta Study

We'll reach out to this number within 24 hrs